Literature DB >> 9712337

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

K R Feingold1, R A Memon, A H Moser, C Grunfeld.   

Abstract

Numerous epidemiological studies have suggested an association between the acute phase response and atherosclerosis. Paraoxonase (PON) is an HDL associated enzyme that protects LDL from oxidative stress. Here we demonstrate that serum PON activity decreases following endotoxin (LPS) administration in Syrian hamsters. This decrease is seen within 24 h following LPS treatment and doses as low as 100 ng/100 g body weight of LPS elicit a reduction in serum PON activity. LPS also induces a marked decrease in PON1 mRNA in the liver (80% decrease). The decrease in mRNA levels is observed as early as 4 h and is sustained for at least 48 h after a single LPS treatment. Moreover, TNF and IL-1, cytokines which mediate the acute phase response, also decrease serum PON activity and PON mRNA levels in the liver. Additionally, TNF and IL-1 treatment of HepG2 cells results in a decrease in PON mRNA levels indicating that these cytokines are capable of directly affecting liver cells. Along with other changes in lipid metabolism that occur during the acute phase response, the decrease in PON could be another factor linking the acute phase response with increased atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712337     DOI: 10.1016/s0021-9150(98)00084-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  48 in total

Review 1.  The paraoxonase gene family and atherosclerosis.

Authors:  David Seo; Pascal Goldschmidt-Clermont
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

2.  The acute phase response inhibits reverse cholesterol transport.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

3.  Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

Review 4.  CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.

Authors:  Gurpreet Kaur; A K Jain; Sandeep Singh
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

5.  Paraoxonase and arylesterase levels in rheumatoid arthritis.

Authors:  A Isik; S S Koca; B Ustundag; H Celik; A Yildirim
Journal:  Clin Rheumatol       Date:  2006-04-27       Impact factor: 2.980

6.  The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats.

Authors:  Rita S Strakovsky; Xiyuan Zhang; Dan Zhou; Yuan-Xiang Pan
Journal:  J Nutr Biochem       Date:  2013-11-06       Impact factor: 6.048

7.  Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.

Authors:  Gabriele Rossi; Amy Richardson; Hali Jamaludin; Cristy Secombe
Journal:  J Vet Diagn Invest       Date:  2020-11-22       Impact factor: 1.279

Review 8.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

9.  Decreased paraoxonase activity in critically ill patients with sepsis.

Authors:  Frantisek Novak; Lucie Vavrova; Jana Kodydkova; Frantisek Novak; Magdalena Hynkova; Ales Zak; Olga Novakova
Journal:  Clin Exp Med       Date:  2009-09-04       Impact factor: 3.984

10.  Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.

Authors:  F Apostolou; I F Gazi; A Kostoula; C C Tellis; A D Tselepis; M Elisaf; E N Liberopoulos
Journal:  J Lipid Res       Date:  2009-06-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.